论文信息 - Does ofloxacin protect against BCG-related toxic effects in patients with bladder cancer? - 字舞流文

Does ofloxacin protect against BCG-related toxic effects in patients with bladder cancer?

[1] F. Saint,et al. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study. , 2006, The Journal of urology.

[2] R. Sylvester,et al. Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer genito-urinary group randomized phase III trial. , 2001, The Journal of urology.

[3] J. Montie,et al. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. , 1999, The Journal of urology.

[4] A. Böhle,et al. The quality of life during intravesical bacillus Calmette-Guerin therapy. , 1996, The Journal of urology.

[5] A. Morales. The Quality of Life During Intravesical Bacillus Calmette-Guerin Therapy , 1996 .